Literature DB >> 2499113

Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens.

K Ikuta1, C Morita, S Miyake, T Ito, M Okabayashi, K Sano, M Nakai, K Hirai, S Kato.   

Abstract

MT-4 cells persistently infected with human immunodeficiency virus type 1 (HIV-1) (MT-4/HIV-1) were recently isolated (K. Ikuta, C. Morita, M. Nakai, N. Yamamoto, and S. Kato, Japan. J. Cancer Res. (Gann), 79, 418-423, 1988). Mouse hybridoma cell clones producing monoclonal antibodies (MoAbs) to HIV-1 gag p24 and p18, and pol reverse transcriptase (RT) were isolated by using this MT-4/HIV-1 cell line for the screening of MoAb production by the immunofluorescence (IF) test. By indirect IF tests of acetone-fixed cells with these MoAbs, the IF intensities in MT-4/HIV-1 cells were found to be higher than those in the other HIV-1 infected cells, such as MOLT-4/HIV-1, HL-60/HIV-1, and U937/HIV-1 cells. Cell surface expression of the HIV-1 gag p24 and p18 antigens examined by IF and radioimmune techniques with these MoAbs revealed the p24 and p18 antigens to be expressed strongly on the cell surface of MT-4/HIV-1 cells and faintly on the cell surface of MOLT-4/HIV-1 cells, respectively. However, monoclonal antibody isolated in the present study failed to detect pol RT antigen on the surface of MT-4/HIV-1 cells. These results indicate that the gag p24 and p18 antigens are expressed, at least in part, on the surface of HIV-1-infected cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499113     DOI: 10.1016/0042-6822(89)90431-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA.

Authors:  M Kameoka; T Kimura; Y Okada; K Fujinaga; T Nakaya; H Takahashi; M Kishi; K Ikuta
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

2.  Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells.

Authors:  M Kameoka; T Kimura; Y H Zheng; S Suzuki; K Fujinaga; R B Luftig; K Ikuta
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  A defective proviral DNA with a 2.6-kb deletion of human immunodeficiency virus type 1 (HIV-1) in a persistently HIV-1 infected cell clone.

Authors:  H Imai; K Maotani-Imai; Y S Shin; K Ikuta; S Suehiro; T Kurimura; S Kato; K Hirai
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

4.  Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.

Authors:  M Yunoki; K Maotani-Imai; H Kusuda; M Motoyama; S Miyake; H Imai; Y S Shin; S Kato; K Sano; C Morita
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.

Authors:  T Goto; K Ikuta; J J Zhang; C Morita; K Sano; M Komatsu; H Fujita; S Kato; M Nakai
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.

Authors:  A Achour; O Picard; D Zagury; P S Sarin; R C Gallo; P H Naylor; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.

Authors:  A Corbin; A C Prats; J L Darlix; M Sitbon
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.

Authors:  T Miyazawa; M Fukasawa; A Hasegawa; N Maki; K Ikuta; E Takahashi; M Hayami; T Mikami
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene.

Authors:  M Miyazawa; J Nishio; B Chesebro
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Altered cell tropism and cytopathicity of feline immunodeficiency viruses in two different feline CD4-positive, CD8-negative cell lines.

Authors:  K Tokunaga; Y Nishino; H Oikawa; C Ishihara; T Mikami; K Ikuta
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.